189 related articles for article (PubMed ID: 25268202)
1. Myxoinflammatory fibroblastic sarcoma: morphologic and genetic updates.
Ieremia E; Thway K
Arch Pathol Lab Med; 2014 Oct; 138(10):1406-11. PubMed ID: 25268202
[TBL] [Abstract][Full Text] [Related]
2. The t(1;10)(p22;q24) TGFBR3/MGEA5 Translocation in Pleomorphic Hyalinizing Angiectatic Tumor, Myxoinflammatory Fibroblastic Sarcoma, and Hemosiderotic Fibrolipomatous Tumor.
Liu H; Sukov WR; Ro JY
Arch Pathol Lab Med; 2019 Feb; 143(2):212-221. PubMed ID: 29979612
[TBL] [Abstract][Full Text] [Related]
3. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
4. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
5. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
[TBL] [Abstract][Full Text] [Related]
6. Deep sequencing of myxoinflammatory fibroblastic sarcoma.
Arbajian E; Hofvander J; Magnusson L; Mertens F
Genes Chromosomes Cancer; 2020 May; 59(5):309-317. PubMed ID: 31898851
[TBL] [Abstract][Full Text] [Related]
7. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
8. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.
Hallor KH; Sciot R; Staaf J; Heidenblad M; Rydholm A; Bauer HC; Aström K; Domanski HA; Meis JM; Kindblom LG; Panagopoulos I; Mandahl N; Mertens F
J Pathol; 2009 Apr; 217(5):716-27. PubMed ID: 19199331
[TBL] [Abstract][Full Text] [Related]
9. Myxoinflammatory fibroblastic sarcoma with complex supernumerary ring chromosomes composed of chromosome 3 segments.
Mansoor A; Fidda N; Himoe E; Payne M; Lawce H; Magenis RE
Cancer Genet Cytogenet; 2004 Jul; 152(1):61-5. PubMed ID: 15193443
[TBL] [Abstract][Full Text] [Related]
10. Hemosiderotic Fibrolipomatous Tumor, Pleomorphic Hyalinizing Angiectatic Tumor, and Myxoinflammatory Fibroblastic Sarcoma: Related or Not?
Boland JM; Folpe AL
Adv Anat Pathol; 2017 Sep; 24(5):268-277. PubMed ID: 28375867
[TBL] [Abstract][Full Text] [Related]
11. Myxoinflammatory fibroblastic sarcoma: a case report.
Ertener O; Tuna B; Akçali O; Yörükoğlu K
Acta Orthop Traumatol Turc; 2013; 47(6):436-9. PubMed ID: 24509225
[TBL] [Abstract][Full Text] [Related]
12. Myxoinflammatory fibroblastic sarcoma showing t(2;6)(q31;p21.3) as a sole cytogenetic abnormality.
Ida CM; Rolig KA; Hulshizer RL; Van Dyke DL; Randolph JL; Jenkins RB; Nascimento AG; Oliveira AM
Cancer Genet Cytogenet; 2007 Sep; 177(2):139-42. PubMed ID: 17854670
[TBL] [Abstract][Full Text] [Related]
13. Targeted RNA-sequencing identifies FBXW4 instead of MGEA5 as fusion partner of TGFBR3 in pleomorphic hyalinizing angiectatic tumor.
Rougemont AL; Berczy M; Lin Marq N; McKee TA; Christinat Y
Virchows Arch; 2019 Aug; 475(2):251-254. PubMed ID: 30911815
[TBL] [Abstract][Full Text] [Related]
14. Myxoinflammatory Fibroblastic Sarcoma: Review and Update.
Lucas DR
Arch Pathol Lab Med; 2017 Nov; 141(11):1503-1507. PubMed ID: 29072951
[TBL] [Abstract][Full Text] [Related]
15. Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link.
Elco CP; Mariño-Enríquez A; Abraham JA; Dal Cin P; Hornick JL
Am J Surg Pathol; 2010 Nov; 34(11):1723-7. PubMed ID: 20871391
[TBL] [Abstract][Full Text] [Related]
16. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.
Suster D; Michal M; Huang H; Ronen S; Springborn S; Debiec-Rychter M; Billings SD; Goldblum JR; Rubin BP; Michal M; Suster S; Mackinnon AC
Mod Pathol; 2020 Dec; 33(12):2520-2533. PubMed ID: 32514165
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.
Nishio J; Nakayama S; Aoki M
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256198
[TBL] [Abstract][Full Text] [Related]
18. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
Wangsiricharoen S; Ali SZ; Wakely PE
J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
[TBL] [Abstract][Full Text] [Related]
19. Aggressive myxoinflammatory fibroblastic sarcoma with multiple site metastases.
Srivastava P; Husain N; Neyaz A; Gupta V
BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30021730
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
